| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.512 | 65 | 2.891 | 16.452 | 16.084 | 19.948 | 21.864 | 27.962 | 34.382 | 35.186 |
| Total Income - EUR | 2.512 | 65 | 2.891 | 16.455 | 16.081 | 19.949 | 21.874 | 28.029 | 34.400 | 37.146 |
| Total Expenses - EUR | 7.210 | 1.358 | 58 | 1.930 | 8.840 | 8.059 | 14.227 | 13.495 | 16.618 | 16.773 |
| Gross Profit/Loss - EUR | -4.698 | -1.293 | 2.832 | 14.525 | 7.240 | 11.890 | 7.647 | 14.535 | 17.781 | 20.373 |
| Net Profit/Loss - EUR | -4.773 | -1.294 | 2.746 | 14.032 | 6.758 | 11.336 | 7.069 | 13.711 | 15.290 | 17.316 |
| Employees | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bioem Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 1.270 | 2.837 | 981 | 3.919 | 12.012 | 8.696 |
| Current Assets | 207 | 49 | 1.487 | 9.319 | 9.091 | 13.260 | 21.446 | 9.986 | 13.678 | 28.972 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 77 | 1 | 0 | 0 | 2 | 1 | 1 | 2.958 | 1 | 1 |
| Cash | 130 | 47 | 1.487 | 9.319 | 9.089 | 13.260 | 21.445 | 7.029 | 13.677 | 28.970 |
| Shareholders Funds | -6.834 | -8.059 | -5.177 | 8.950 | 10.287 | 15.907 | 22.624 | 13.759 | 25.062 | 37.922 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.042 | 8.107 | 6.663 | 369 | 177 | 275 | 166 | 222 | 887 | 509 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bioem Med Srl